The present invention provides compounds for targeting endothelial cells,
tumor cells or other cells that express the NP-1 receptor, compositions
containing the same and methods for their use. Additionally, the present
invention includes diagnostic, therapeutic and radiotherapeutic
compositions useful for visualization, therapy or radiotherapy.